Examples of other antiangiogenic agents that also exhibit antifibrotic activity include endostatin and IFN‐gamma inducible protein 10.17, 36 Antiangiogenic factors may also modulate fibrosis via suppression of inflammation which often precedes fibrosis in SSc lung involvement. This evidence concerns the gene COL18A1 and systemic sclerosis.